VeriMom¿Es sodium c12-15 pareth-7 sulfonate seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- ¿Es sodium c12-15 pareth-7 sulfonate seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
- ¿Es sodium c12-15 pareth-7 sulfonate seguro durante la lactancia?
- No evidence of reproductive or lactation-related toxicity or known mechanisms for transfer into breast milk for this ingredient; no harmonised hazard classification. Dermal cosmetic use implies low but measurable maternal systemic exposure, so a low exposure score is used. Sources: ECHA records (no harmonised classification), CosIng/PubChem (no lactation concerns), absence of CIR/SCCS warnings.
- ¿Es sodium c12-15 pareth-7 sulfonate seguro para la piel del bebé?
- No infant-specific reproductive or developmental hazards identified for this surfactant. However, immature infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 from adult (adult e=1 → infant e=2). No infant-specific adverse data found in regulatory or peer-reviewed sources. Sources: CosIng/PubChem (ingredient identity and typical use), ECHA (no harmonised classification), toxicology literature absence per CIR/SCCS practice.
- ¿Cómo puntúa VeriMom a sodium c12-15 pareth-7 sulfonate?
- VeriMom puntúa sodium c12-15 pareth-7 sulfonate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a sodium c12-15 pareth-7 sulfonate en el embarazo?
- Consulta nuestra lista de alternativas seguras a sodium c12-15 pareth-7 sulfonate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.